Citation Impact
Citing Papers
Cell culture-grown hepatitis C virus is infectious in vivo and can be recultured in vitro
2006 StandoutNobel
Complete Replication of Hepatitis C Virus in Cell Culture
2005 StandoutScienceNobel
Characterization of a canine homolog of hepatitis C virus
2011 StandoutNobel
Plasmacytoid dendritic cells initiate a complex chemokine and cytokine network and are a viable drug target in chronic HCV patients
2007 StandoutNobel
Evidence for a functional RNA element in the hepatitis C virus core gene
2007 StandoutNobel
Crystal structure of SARS-CoV-2 main protease provides a basis for design of improved α-ketoamide inhibitors
2020 StandoutScience
Three conformational snapshots of the hepatitis C virus NS3 helicase reveal a ratchet translocation mechanism
2009 StandoutNobel
Frailty in Older Adults: Evidence for a Phenotype
2001 Standout
Murine liver repair via transient activation of regenerative pathways in hepatocytes using lipid nanoparticle-complexed nucleoside-modified mRNA
2021 StandoutNobel
Nucleoside-modified VEGFC mRNA induces organ-specific lymphatic growth and reverses experimental lymphedema
2021 StandoutNobel
The Spring α-Helix Coordinates Multiple Modes of HCV (Hepatitis C Virus) NS3 Helicase Action
2016 StandoutNobel
Challenges and successes in developing new therapies for hepatitis C
2005 Nature
SEC14L2 enables pan-genotype HCV replication in cell culture
2015 StandoutNatureNobel
The Nonstructural Protein 3 Protease/Helicase Requires an Intact Protease Domain to Unwind Duplex RNA Efficiently
2004
Kinetic Analysis of C-Terminally Truncated RNA-Dependent RNA Polymerase of Hepatitis C Virus
2002
euHCVdb: the European hepatitis C virus database
2006 StandoutNobel
Unravelling hepatitis C virus replication from genome to function
2005 StandoutNatureNobel
Vascular Endothelial Growth Factor-Delivery Systems for Cardiac Repair: An Overview
2012
mRNA-Based Protein Replacement Therapy for the Heart
2018
Control of β-Catenin Phosphorylation/Degradation by a Dual-Kinase Mechanism
2002 Standout
Unconventional miR-122 binding stabilizes the HCV genome by forming a trimolecular RNA structure
2013 StandoutNobel
Shared Principles in NF-κB Signaling
2008 Standout
Two Novel Conserved Motifs in the Hepatitis C Virus NS3 Protein Critical for Helicase Action
2003
Evolutionarily Conserved Roles of the Dicer Helicase Domain in Regulating RNA Interference Processing
2014 StandoutNobel
Inhibition of glycogen synthase kinase-3 by insulin mediated by protein kinase B
1995 StandoutNature
Missing Pieces in the NF-κB Puzzle
2002 Standout
De Novo Initiation of Viral RNA-Dependent RNA Synthesis
2001
microRNA-Directed Phasing during Trans-Acting siRNA Biogenesis in Plants
2005 Standout
Production of Authentic SARS-CoV Mpro with Enhanced Activity: Application as a Novel Tag-cleavage Endopeptidase for Protein Overproduction
2006
DEAD-box proteins: the driving forces behind RNA metabolism
2004
Requirement for glycogen synthase kinase-3β in cell survival and NF-κB activation
2000 Nature
A β-arrestin 2 Signaling Complex Mediates Lithium Action on Behavior
2008 StandoutNobel
A role for Wnt signalling in self-renewal of haematopoietic stem cells
2003 StandoutNature
Inactivation of Glycogen Synthase Kinase-3 by Epidermal Growth Factor Is Mediated by Mitogen-activated Protein Kinase/p90 Ribosomal Protein S6 Kinase Signaling Pathway in NIH/3T3 Cells
1995 Nobel
Axin, a negative regulator of the Wnt signaling pathway, forms a complex with GSK-3beta and beta -catenin and promotes GSK-3beta -dependent phosphorylation of beta -catenin
1998
RNA Polymerase Activity and Specific RNA Structure Are Required for Efficient HCV Replication in Cultured Cells
2010
The efficacy of a ‘master switch gene’ HIF-1α in a porcine model of chronic myocardial ischaemia
2005
Essential Role of the N-terminal Domain in the Regulation of RIG-I ATPase Activity
2008
Glycogen synthase kinase 3 regulates cell fate in dictyostelium
1995
Severe Adverse Cutaneous Reactions to Drugs
1994 Standout
Hepatitis C Virus Entry
2007 StandoutNobel
Structure of the zinc-binding domain of an essential component of the hepatitis C virus replicase
2005 StandoutNatureNobel
CREB1 Encodes a Nuclear Activator, a Repressor, and a Cytoplasmic Modulator that Form a Regulatory Unit Critical for Long-Term Facilitation
1998 StandoutNobel
Repertoires of Autophagy in the Pathogenesis of Ocular Diseases
2015 Standout
Understanding the hepatitis C virus life cycle paves the way for highly effective therapies
2013 StandoutNobel
TSC2 Integrates Wnt and Energy Signals via a Coordinated Phosphorylation by AMPK and GSK3 to Regulate Cell Growth
2006 Standout
Seven-transmembrane receptors
2002 StandoutNobel
Novel Insights into Hepatitis C Virus Replication and Persistence
2004
Angiogenesis as a therapeutic target
2005 StandoutNature
Replication of hepatitis C virus
2007 StandoutNobel
Quantitative Analysis of the Hepatitis C Virus Replication Complex
2005
Ionizable Lipid Nanoparticles for In Vivo mRNA Delivery to the Placenta during Pregnancy
2023 StandoutNobel
Discovery and Structure−Activity Relationship of P1−P3 Ketoamide Derived Macrocyclic Inhibitors of Hepatitis C Virus NS3 Protease
2008
Initiation of viral RNA-dependent RNA polymerization
2004
A molecular mechanism for the effect of lithium on development.
1996 Standout
Nanozymes: Classification, Catalytic Mechanisms, Activity Regulation, and Applications
2019 Standout
Substituted Benzamide Inhibitors of Human Rhinovirus 3C Protease: Structure-Based Design, Synthesis, and Biological Evaluation
2000
The bacterial cell wall as a source of antibacterial targets
2002
Judging a Protein by More Than Its Name: GSK-3
2001
β-Arrestin1 modulates lymphoid enhancer factor transcriptional activity through interaction with phosphorylated dishevelled proteins
2001 StandoutNobel
cis -Acting RNA Signals in the NS5B C-Terminal Coding Sequence of the Hepatitis C Virus Genome
2004
Interferon-Stimulated Genes: A Complex Web of Host Defenses
2014 StandoutNobel
Studying Hepatitis C Virus: Making the Best of a Bad Virus
2007 StandoutNobel
Regulation of apoptosis by the circadian clock through NF-κB signaling
2011 StandoutNobel
Polydopamine Nanoparticles as Efficient Scavengers for Reactive Oxygen Species in Periodontal Disease
2018
Hepatitis C Virus RNA Synthesis in a Cell-Free System Isolated from Replicon-Containing Hepatoma Cells
2003 StandoutNobel
Design, Synthesis, and Evaluation of Oxygen-Containing Macrocyclic Peptidomimetics as Inhibitors of HCV NS3 Protease
2009
The Combinatorial Synthesis of Bicyclic Privileged Structures or Privileged Substructures
2003 Standout
Reactive Oxygen Species (ROS)-Based Nanomedicine
2019 Standout
beta-Catenin associates with the actin-bundling protein fascin in a noncadherin complex.
1996 StandoutNobel
Viral Proteases
2002
Phenytoin hypersensitivity reaction presenting with toxic epidermal necrolysis and severe hepatitis
1985
The cyclin D1 gene is a target of the β-catenin/LEF-1 pathway
1999 Standout
A secondary phosphorylation of CREB341 at Ser129 is required for the cAMP-mediated control of gene expression. A role for glycogen synthase kinase-3 in the control of gene expression.
1994
Regulation of Spemann organizer formation by the intracellular kinase Xgsk-3
1995
Toward an Understanding of Frailty
1999
Protein-Protein Interactions between Hepatitis C Virus Nonstructural Proteins
2003
Chemistry and Biology Of Multicomponent Reactions
2012 Standout
Scanning the human proteome for calmodulin-binding proteins
2005 StandoutNobel
Template Requirements for RNA Synthesis by a Recombinant Hepatitis C Virus RNA-Dependent RNA Polymerase
2000
Structure of the catalytic domain of the hepatitis C virus NS2-3 protease
2006 StandoutNatureNobel
Works of Robert B. Johnson being referenced
Discovery of a novel bicycloproline P2 bearing peptidyl α-ketoamide LY514962 as HCV protease inhibitor
2003
Specificity and Mechanism Analysis of Hepatitis C Virus RNA-Dependent RNA Polymerase
2000
Development ofin VitroPeptide Substrates for Human Rhinovirus-14 2A Protease
1998
P1 and P3 optimization of novel bicycloproline P2 bearing tetrapeptidyl α-ketoamide based HCV protease inhibitors
2003
Protein recovery from several paper types used to collect gingival crevicular fluid
1999
A Continuous Colorimetric Assay for Rhinovirus-14 3C Protease Using Peptidep-Nitroanilides as Substrates
1997
De Novo RNA Synthesis Catalyzed by HCV RNA-Dependent RNA Polymerase
2000
Comparative characterization of two DEAD-box RNA helicases in superfamily II: human translation-initiation factor 4A and hepatitis C virus non-structural protein 3 (NS3) helicase
2002
Novel P4 truncated tripeptidyl α-ketoamides as HCV protease inhibitors
2003
Efficacy of intracoronary or intravenous VEGF165in a pig model of chronic myocardial ischemia
2001
P4 and P1′ optimization of bicycloproline P2 bearing tetrapeptidyl α-ketoamides as HCV protease inhibitors
2004
Comparison of Alveolar Bone Loss, Alveolar Bone Density and Second Metacarpal Bone Density, Salivary and Gingival Crevicular Fluid Interleukin-6 Concentrations in Healthy Premenopausal and Postmenopausal Women on Estrogen Therapy
1997
Activation of Human Rhinovirus-14 3C Protease
2001
P1 and P1; Optimization of [3,4]-Bicycloproline P2 Incorporated Tetrapeptidyl α-Ketoamide Based HCV Protease Inhibitors
2005
Oligomerization and Cooperative RNA Synthesis Activity of Hepatitis C Virus RNA-Dependent RNA Polymerase
2002
Identification and Characterization of a Monofunctional Glycosyltransferase from Staphylococcus aureus
2001
Dual Inhibition of Human Rhinovirus 2A and 3C Proteases by Homophthalimides
1998
Inhibition of human rhinovirus 3C protease by homophthalimides
1997
Pulse therapy. Therapeutic efficacy in the treatment of pyoderma gangrenosum
1982
MDS1, a dosage suppressor of an mck1 mutant, encodes a putative yeast homolog of glycogen synthase kinase 3.
1994
Comparative characterization of two DEAD-box RNA helicases in superfamily II: human translation-initiation factor 4A and hepatitis C virus non-structural protein 3 (NS3) helicase
2002
MDS1, a dosage suppressor of an mck1 mutant, encodes a putative yeast homolog of glycogen synthase kinase 3
1994
Pulse Therapy
1982
Identification of a C-Terminal Regulatory Motif in Hepatitis C Virus RNA-Dependent RNA Polymerase: Structural and Biochemical Analysis
2003